Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Q1 2010/11 Earnings Presentation
7 slides from Coloplast A/s Class B's earnings presentation, Jan 26, 2011
Slide 1: Leading intimate healthcare
Page 1 Leading intimate healthcare Conference Call presentation – Q1 2010/11 26 January 2011 Leading intimate healthcare
Slide 2: Forward-looking statements
Page 2 Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking stat
Slide 3: Key messages
Page 3 Key messages Sales 2.541 +11% • 6% organic sales growth in line with guidance 2.296 • Continued gross margin improvement from 59% to 63% from higher efficiency in production Q1 2009/10 Q1 2010/11 • Very satisfactory EBIT margin of 24% Operating profit • Full year guidance for 2010/11: +35% 61
Slide 4: 6% organic sales growth in line with guidance
Page 4 6% organic sales growth in line with guidance Sales by business area • In DKK, revenues were up by 11% to DKK 2.5bn, and DKKm (organic growth) organic growth was 6% in line with guidance 369 -2% 1,058 • Satisfying Ostomy Care organic growth of 6% continues to 6% be driven by sales of SenSura®
Slide 5: Q1 result confirms strong financial performance record
Page 5 Q1 result confirms strong financial performance record Q1 2010/11 Q1 2009/10 • Improved production economy continues to drive Gross profit 1,612 1,354 gross margin improvements Gross margin 63% 59% • SGA to sales remains stable despite increased investments in sales activities and R&D during
Slide 6: Guidance for 2010/11 confirms current trends, new long-term ambition confirms completion of turn-around
Page 6 Guidance for 2010/11 confirms current trends, new long- term ambition confirms completion of turn-around Guidance Guidance Long-term 10/11 10/11 (DKK) ambition Sales growth 6-8 % (organic) 8-10% Market+ Deliver margins in line with EBIT margin 23-25%(fixed) 23-25% the best performing medical
Slide 7: Coloplast's Capital Market Days 21-22 June 2011
Page 7 Coloplast’s Capital Market Days 21-22 June 2011 SAVE THE DATES for Coloplast's Capital Market Days in Hungary in June 2011, Wednesday 22 June (08:00-17:00) with two days of very interesting topics. The day will be held at our Tatabanya production facility and will include both presentations b